Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Baronciani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hematological Oncology|January 29, 2015
Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre studyDonatella Baronciani, Cristina Depau, Clara Targhetta, et al.
American Journal of Hematology|October 28, 2014
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivoSilvana Anna Maria Urru, Igor Tandurella, Mario Capasso, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Hematopietic stem cell transplantation in thalassemia and related disordersEmanuele Angelucci, Federica Pilo, Clara Targhetta, et al.
American Journal of Hematology|July 16, 2008
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patientsDonatella Baronciani, Alessandro Rambaldi, Anna Paola Iori, et al.
Blood|June 19, 2002
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantationEmanuele Angelucci, Pietro Muretto, Antonio Nicolucci, et al.
Hemasphere|May 10, 2021
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making AlgorithmDonatella Baronciani, Maddalena Casale, Lucia De Franceschi, et al.
Blood|March 25, 2004
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 yearsPietro Sodani, David Gaziev, Paola Polchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Franco Aversa, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Haematologica|May 3, 2014
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panelEmanuele Angelucci, Susanne Matthes-Martin, Donatella Baronciani, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hematological Oncology|January 29, 2015
Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre studyDonatella Baronciani, Cristina Depau, Clara Targhetta, et al.
American Journal of Hematology|October 28, 2014
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivoSilvana Anna Maria Urru, Igor Tandurella, Mario Capasso, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Hematopietic stem cell transplantation in thalassemia and related disordersEmanuele Angelucci, Federica Pilo, Clara Targhetta, et al.
American Journal of Hematology|July 16, 2008
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patientsDonatella Baronciani, Alessandro Rambaldi, Anna Paola Iori, et al.
Blood|June 19, 2002
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantationEmanuele Angelucci, Pietro Muretto, Antonio Nicolucci, et al.
Hemasphere|May 10, 2021
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making AlgorithmDonatella Baronciani, Maddalena Casale, Lucia De Franceschi, et al.
Blood|March 25, 2004
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 yearsPietro Sodani, David Gaziev, Paola Polchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Franco Aversa, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Haematologica|May 3, 2014
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panelEmanuele Angelucci, Susanne Matthes-Martin, Donatella Baronciani, et al.
Pageof 2